COPD association and repeatability of blood biomarkers in the ECLIPSE cohort (Q35637295)

9 August 2017

title

COPD association and repeatability of blood biomarkers in the ECLIPSE cohort (English)

1 reference

chronic obstructive pulmonary disease

9 August 2017

0 references

1 reference

6

Ruth Tal-Singer

1 reference

9 August 2017

Lisa D Edwards

3

1 reference

ORCID Public Data File 2021

author name string

Jennifer A Dickens

1

1 reference

9 August 2017

Bruce E Miller

2

1 reference

9 August 2017

Edwin K Silverman

4

1 reference

9 August 2017

David A Lomas

5

1 reference

9 August 2017

Evaluation of COPD Longitudinally to Identify Surrogate Endpoints (ECLIPSE) study investigators

7

1 reference

9 August 2017

publication date

4 November 2011

1 reference

9 August 2017

1 reference

9 August 2017

volume

12

1 reference

9 August 2017

page(s)

146

1 reference

Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD.

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

Systemic inflammation in chronic obstructive pulmonary disease: a population-based study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

Immunologic aspects of chronic obstructive pulmonary disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

"Fit-for-purpose" method validation and application of a biomarker (C-terminal telopeptides of type 1 collagen) in denosumab clinical studies

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

Natural histories of chronic obstructive pulmonary disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

Outcomes for COPD pharmacological trials: from lung function to biomarkers.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

Profiling serum biomarkers in patients with COPD: associations with clinical parameters

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

C-reactive protein in patients with COPD, control smokers and non-smokers

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

COPD, a multicomponent disease: implications for management

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

Chronic obstructive pulmonary disease: molecular and cellularmechanisms

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

Adjusting for multiple testing--when and how?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

Serum ECP and MPO are increased during exacerbations of chronic bronchitis with airway obstruction

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

An increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPD.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

Serum surfactant protein D during acute exacerbations of chronic obstructive pulmonary disease.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

The effects of inhaled and oral corticosteroids on serum inflammatory biomarkers in COPD: an exploratory study.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

Pulmonary and systemic hepatocyte and keratinocyte growth factors in patients with chronic obstructive pulmonary disease

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

Increased systemic inflammation is a risk factor for COPD exacerbations

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

Increased activity of matrix metalloproteinase-8 and matrix metalloproteinase-9 in induced sputum from patients with COPD.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

All- trans Retinoic Acid Modulates the Balance of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Patients With Emphysema *

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

25 September 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-146

Systemic Inflammation and COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-146

Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-146

Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-146

Pathogenesis of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3247194

Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort

23 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-146

Plasma markers of inflammation and incidence of hospitalisations for COPD: results from a population-based cohort study

21 January 2018

1 reference

12 December 2020

Plasma leptin and adiponectin in COPD exacerbations: Associations with inflammatory biomarkers

1 reference

12 December 2020

Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study

1 reference

12 December 2020

Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels

1 reference

12 December 2020

Elevated Plasma Fibrinogen Associated with Reduced Pulmonary Function and Increased Risk of Chronic Obstructive Pulmonary Disease

1 reference

12 December 2020

Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease

1 reference

12 December 2020

Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease

1 reference

12 December 2020

Inflammatory changes, recovery and recurrence at COPD exacerbation

1 reference

12 December 2020

Elevated circulating plasma adiponectin in underweight patients with COPD

1 reference

12 December 2020

Biomarkers of systemic inflammation in stable and exacerbation phases of COPD

1 reference

12 December 2020

Identifiers

DOI

10.1186/1465-9921-12-146

1 reference

Dimensions Publication ID

9 August 2017

0 references

1 reference

9 August 2017

1 reference